| Authors: |
Weaver RJ; a Research & Biopharmacy, Institut de Recherches Internationales Servier , Suresnes , France., Betts C; b Pathology Sciences, Drug Safety and Metabolism , AstraZeneca R&D , Cambridge , UK., Blomme EAG; c Preclinical Safety , AbbVie , North Chicago , USA., Gerets HHJ; d Non Clinical Development, Chemin du Foriest , UCB BioPharma SPRL , Braine L'Alleud , Belgium., Gjervig Jensen K; e Drug ADME Research, H. Lundbeck A/S , 9 Ottiliavej , Valby , Denmark., Hewitt PG; f Non-Clinical Development, Merck KGaA , Darmstadt , Germany., Juhila S; g In Vitro Biology , Orion Pharma , Espoo , Finland., Labbe G; h Investigative Toxicology, Preclinical Safety , Sanofi R&D , Paris , France., Liguori MJ; c Preclinical Safety , AbbVie , North Chicago , USA., Mesens N; i Preclinical Development & Safety, Janssen (Pharmaceutical Companies of Johnson & Johnson) Turnhoutseweg 30 , Beerse , Belgium., Ogese MO; j Pathology Sciences, Drug Safety and Metabolism , AstraZeneca R&D , Cambridge , UK., Persson M; k Innovative Medicines and Early Clinical Development, Drug Safety and Metabolism, Discovery Safety , AstraZeneca R&D , Mölndal , Sweden., Snoeys J; l Pharmacokinetics Dynamics & Metabolism, Janssen (Pharmaceutical Companies of Johnson & Johnson) Turnhoutseweg 30 , Beerse , Belgium., Stevens JL; m Dept of Toxicology , Lilly Research Laboratories, Eli Lilly and Company , Indianapolis , Indiana , USA., Walker T; n Investigative Safety & Drug Metabolism , GlaxoSmithKline, David Jack Centre for Research and Development , Ware , Herts , Hertfordshire, UK., Park BK; o Institute of Translational Medicine , University of Liverpool , Liverpool , UK. |
